215
Views
2
CrossRef citations to date
0
Altmetric
Articles

The siRNAs targeting the left or right terminal region of chrysanthemum stunt viroid (CSVd) sequence suppress the development of disease symptoms caused by CSVd infection of chrysanthemum, but do not suppress viroid propagation

, , , , , , , & ORCID Icon show all
Pages 491-499 | Accepted 01 Nov 2017, Published online: 22 Nov 2017
 

ABSTRACT

Transgenic chrysanthemum plants harbouring the genes producing small interfering RNAs (siRNAs) whose sequence was designed based on the chrysanthemum stunt viroid (CSVd) genome were established. The siRNAs are expected to target and decompose CSVd RNA through a silencing mechanism. The CSVd-infected plants were grafted as scions onto the stocks of either non-transgenic or transgenic plants, and axial shoots that elongated from the stocks were rooted and grown to investigate if the plants are resistant to CSVd under greenhouse conditions. The non-transgenic plants infected with CSVd showed severe disease symptoms, i.e. stunted growth and spotty chlorotic lesions on leaves, but no such symptoms were observed in the transgenic plants. The real-time quantitative reverse transcription PCR for monitoring the amounts of CSVd indicated that CSVd equally accumulated in both non-transgenic and transgenic plants. The present results suggest that the resistant feature of the transgenic plants to CSVd was due to interference with the pathway of symptom development, and not the inhibition of CSVd replication.

Acknowledgements

This article contains the results of experiments conducted in the BL1-P greenhouse at Kyoto Prefectural University (KPU). We thank KPU and Kyoto Prefecture for financial help in constructing the facility. We thank to Ms Sayaka Tsujioka and Ms Yuka Nishimura for their helpful technical support for the RNA gel blot analysis.

Supplemental data for this article can be accessed here.

Disclosure statement

No potential conflict of interest was reported by the author.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.